Import 4,7-Dibromo-2,1,3-Benzothiadiazole — Buy in Bulk from Supplier in China

4,7-DIBROMO-2,1,3-Benzothiadiazole is a brominated heterocyclic compound with the molecular formula C6H2Br2N2S, supplied by Suzhou Stone Lake Pharma Tech Co., Ltd. from its facility in Jiangsu. The compound is produced under controlled conditions to ensure consistent purity, making it suitable for applications in electronic and photonic devices where thermal and chemical stability are critical. Its structure includes a benzothiadiazole core with bromine substituents at the 4 and 7 positions, which influence its reactivity and compatibility with other reagents.

The material is typically used as an intermediate in the synthesis of dyes, pigments, and specialty chemicals, particularly in industries requiring precise molecular architectures. Standard grades for such compounds often target purity levels above 97% to minimize side reactions, and the product is expected to exhibit low volatility and good solubility in organic solvents. Suzhou Stone Lake Pharma Tech Co., Ltd. positions this compound for laboratory, R&D, and production-scale use, with packaging designed to preserve its stability during transit.

Industrial buyers in the chemical, manufacturing, and research sectors source this compound for its role in advanced formulations. The product is compatible with common organic synthesis methods, including coupling and substitution reactions. Buyers should confirm packaging formats, as the supplier offers secure options for bulk and smaller quantities. Lead times and incoterms such as CIF or FOB are available upon request, with the supplier’s location in Suzhou providing logistical advantages for exports from China.

Suzhou Stone Lake Pharma Tech Co., Ltd. is based in Building 5, 2358 Changan Road, Scientific Innovation Park, Suzhou, Jiangsu Province, China. The company operates as an imported-tier supplier, with its trust tier classified as harbor. Its address places it within a recognized industrial and scientific hub, which supports its focus on chemical intermediates and specialty compounds for global markets.

The supplier’s profile indicates no recorded response rate or average response hours, which suggests buyers should proactively confirm details such as lead times, incoterms, and quality documentation. Suzhou Stone Lake Pharma Tech Co., Ltd. does not list certifications or client references in its available data, so verification of compliance with industry standards must be requested directly. The company’s location in Suzhou provides access to major ports and logistics networks for efficient export.